We are live on ! Find out more
KA

Kozak & Associates Portfolio holdings

AUM $576M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
-5.73%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
–
AUM
$401M
AUM Growth
-$36.6M
Cap. Flow
+$8.16M
Cap. Flow %
2.03%
Top 10 Hldgs %
74.52%
Holding
473
New
34
Increased
162
Reduced
52
Closed
17

Top Buys

Rank Stock Value
1
RWL icon
Invesco S&P 500 Revenue ETF
RWL
+$2M
2
IETC icon
iShares US Tech Independence Focused ETF
IETC
+$1.37M
3
SMH icon
VanEck Semiconductor ETF
SMH
+$950K
4
IYJ icon
iShares US Industrials ETF
IYJ
+$925K
5
IYG icon
iShares US Financial Services ETF
IYG
+$639K

Top Sells

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$168K
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$122K
3
XSMO icon
Invesco S&P SmallCap Momentum ETF
XSMO
+$103K
4
SCHW
Charles Schwab
SCHW
+$99.3K
5
JNJ icon
Johnson & Johnson
JNJ
+$97.6K

Sector Composition

Rank Sector Weight
1 Technology 15.57%
2 Consumer Staples 5.36%
3 Consumer Discretionary 4.81%
4 Financials 2.43%
5 Communication Services 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCC
451
CCC Intelligent Solutions
CCC
$4.08B
– –
0
– –
NICE icon
452
Nice
NICE
$5.97B
– –
0
– –
PATH icon
453
UiPath
PATH
$7.8B
– –
0
– –
WIT icon
454
Wipro
WIT
$20B
$3 ﹤0.01%
1
– –
ALEX
455
DELISTED
Alexander & Baldwin
ALEX
– –
0
– –
CEVA icon
456
CEVA Inc
CEVA
$1.08B
– –
0
– –
SYNA icon
457
Synaptics
SYNA
$4.15B
– –
0
– –
XMTR icon
458
Xometry
XMTR
$5.34B
– –
0
– –
NNDM
459
Nano Dimension
NNDM
$343M
$1 ﹤0.01%
1
– –
PAHC icon
460
Phibro Animal Health
PAHC
$1.39B
– –
0
– –
SSTK icon
461
Shutterstock
SSTK
$219M
– –
0
– –
AGG icon
462
iShares Core US Aggregate Bond ETF
AGG
$138B
– –
-268
Closed -$25.9K
BIL icon
463
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
– –
-490
Closed -$44.8K
DBMF icon
464
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.13B
– –
-338
Closed -$8.9K
EFV icon
465
iShares MSCI EAFE Value ETF
EFV
$29.4B
– –
-210
Closed -$11K
MOAT icon
466
VanEck Morningstar Wide Moat ETF
MOAT
$12.3B
– –
-73
Closed -$6.76K
PDBC icon
467
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.3B
– –
-180
Closed -$2.35K
TOTL icon
468
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.03B
– –
-306
Closed -$12.1K
TRMD icon
469
TORM
TRMD
$3.02B
– –
-250
Closed -$5.03K
PCCE icon
470
Polen Capital China Growth ETF
PCCE
$1.6M
– –
-488
Closed -$5.25K
PCIG icon
471
Polen Capital International Growth ETF
PCIG
$28.9M
– –
-1,170
Closed -$10.7K
ALTM
472
DELISTED
Arcadium Lithium plc
ALTM
– –
-553
Closed -$2.91K
AMLI
473
DELISTED
American Lithium Corp. Common Stock
AMLI
– –
-990
Closed -$413
15 16 17 18
19

Similar funds

SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return

Kozak & Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Kozak & Associates held 473 positions worth $401M, down 8.4% from $437M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Kozak & Associates's Q1 2025 filing shows 34 new, 162 increased, 52 reduced and 17 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 324 shares worth $104K. The largest sale was Block Inc, an estimated $168K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Kozak & Associates's largest Q1 2025 buy was Madrigal Pharmaceuticals: 324 shares worth $104K.
  • Kozak & Associates added most to Invesco S&P 500 Revenue ETF in Q1 2025, an estimated $2M increase.
  • Kozak & Associates's biggest Q1 2025 reduction was Block Inc, cutting an estimated $168K.
  • Kozak & Associates fully exited State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2025, selling an estimated $44.8K.
  • Kozak & Associates's ten largest holdings make up 75% of its $401M portfolio in Q1 2025.
  • Kozak & Associates opened 34 new positions and closed 17 in Q1 2025.
  • Kozak & Associates's portfolio value fell 8.4% quarter-over-quarter to $401M.

Based on Kozak & Associates's 13F filing for Q1 2025, filed 15 Apr 2025.